• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PSNL

PSNL

Personalis, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD10.78

-0.36 (-3.23%)

Rating:C+

Company Profile

CEO

Christopher Hall

IPO Date

2019-06-20

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.98

Prev. Close

$11.14

Day Low

$10.37

Day High

$11.05

52W Low

$3.84

52W High

$11.85

Market Cap

$0.96B

Volume

2.90M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

31.4%

Avg Negative

4.7%

Avg Neutral

63.9%

News Feed

Personalis: Market-Leading Immuno-Oncology Platform Drives Consistent Long-Term Growth

Seeking Alpha·6/21/2021·↑ positive

Personalis, Inc. to Present at Biomarkers Week Online 2021

Business Wire·5/17/2021·↑ positive

Personalis, Inc. (PSNL) CEO John West on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/5/2021·↓ negative

Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

Personalis (PSNL) Stock Jumps 7.9%: Will It Continue to Soar?

Zacks Investment Research·4/1/2021·↑ positive

PSNL Stock Price Increased 10.14%: Why It Happened

Pulse2·3/30/2021·↑ positive

Personalis Announces Changes to its Board of Directors

Business Wire·3/8/2021·↓ negative

Personalis, Inc. (PSNL) CEO John West on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/28/2021·↓ negative

CORRECTING and REPLACING Personalis to Report Fourth Quarter 2020 Financial Results on February 25, 2021

Business Wire·2/22/2021·↓ negative

Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer

Business Wire·2/8/2021·↑ positive